Phathom Pharmaceuticals (PHAT) Receivables - Other (2018)

Phathom Pharmaceuticals' (PHAT) quarterly Receivables - Other came in at $19000.0 in Q4 2018.

Phathom Pharmaceuticals (PHAT) Receivables - Other (2018) Analysis & Trends

Phathom Pharmaceuticals (PHAT) has 1 years of Receivables - Other data on file, last reported at $19000.0 in Q4 2018.

On a quarterly basis, Receivables - Other changed N/A year-over-year to $19000.0 in Q4 2018; TTM through Dec 2018 was $19000.0, a N/A change from a year earlier, with the FY2018 full-year figure at $19000.0, changed N/A from the prior year.
Receivables - Other for Q4 2018 stood at $19000.0.
Over the last five years, Receivables - Other for PHAT reached as high as $19000.0 in Q4 2018 and fell as low as $19000.0 in Q4 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Phathom Pharmaceuticals	951.79 Mn	768.02 Mn	46.31 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2018	19,000.00
Dec 31, 2018	19,000.00